Fate Therapeutics, Inc.
$2.43
-0.11 (-4.33%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -3.2%
- 3 Months
- -14.4%
- YTD
- +147.3%
- 1 Year
- +117.0%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 96.0%
- Largest decline max drawdown, since Aug 2025
- -41.6%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.27
Own FATE?
See how FATE contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.